Expression and clinical significance of HMGB1 and sRAGE in patients with systemic sclerosis

XU Xue,CHU Hai-yan,LIANG Min-rui,WU Wen-yu,WANG Jiu-cun,ZOU He-jian

2012-01-01

Abstract:To determine the protein and gene levels of HMGB1 and sRAGE in the patients with systemic sclerosis,to analyze their clinical significance,thirty limited systemic scleroderma patients(lSSc) and thirty diffuse systemic scleroderma patients(dSSc) were recruited and forty healthy volunteers were recruited as normal controls.Plasma protein and mRNA levels of HMGB1 and sRAGE in peripheral blood were measured by enzyme-linked immunosorbent assay(ELISA) and real-time RT-PCR respectively.To further explore the relationship between HMGB1/sRAGE and clinical or laboratory indexes of scleroderma patients.The plasma concentrations of HMGB1 and sRAGE were significantly increased in dSSc and lSSc patients as compared to the normal controls(P<0.05).The levels of plasma HMGB1 showed a positive correlation with the levels of plasma sRAGE in both lSSc and dSSc patients.The relative mRNA levels of HMGB1 were elevated in both kinds of patients compared to normal controls.The levels of plasma HMGB1 and sRAGE were significantly increased in SSc patients with involve of lung or kidney than those without involve of lung or kidney(P<0.05).Meanwhile,the levels of plasma HMGB1 and sRAGE were significantly increased in SSc patients with anti-histone antibody-positive group or anti-RNA polymerase Ⅲ antibody positive group than the antibody-negative groups.However,the levels of plasma HMGB1 and sRAGE were significantly decreased in SSc patients with anti-centromere antibody positive group than antibody-negative group.Both HMGB1 and sRAGE expression levels in SSc patients are significantly elevated and the close relationship between HMGB1 and sRAGE levels and several clinical and laboratory indexes suggests that the two protein may play an important role in the pathogenesis of scleroderma and may be a promising target to assess the activity of disease.